Iron Deficiency Anemia Treatment
24
2
3
17
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.2%
1 terminated out of 24 trials
94.4%
+7.9% vs benchmark
25%
6 trials in Phase 3/4
6%
1 of 17 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 17 completed trials
Clinical Trials (24)
The Role of Ferric Carboxymaltose in the Treatment of Pediatric Iron Deficiency Anemia in the Emergency Department
Optimizing Dosing Strategies in Oral Iron Supplementation
Alternative vs. Once-Daily Oral Iron Supplementation in Iron Deficiency Anemia (IDA)
Effectiveness of Oral Iron Therapy in Iron Deficiency Anemia With Daily vs Alternate Day Dosing
Iron and COVID-19 Vaccine Response
Patient Blood Management In CARdiac sUrgical patientS
Evaluate the Outcomes of Ferric Carboxymaltose in Patients With Perioperative Anemia
GI Effects of Iron in Healthy Volunteers
Neuroimaging Ancillary Study
Patient Blood Management in Patients Scheduled for Cardiac Surgery
How Does Perimenopausal Menorrhagia Affect Women's Quality of Life and Cognitive Function?
Meals to Improve Absorption of Iron Supplements
Daily Versus Alternate Day Regimen of Iron Supplementation in Children with Iron Deficiency Anemia
Probiotic Use in Oral Iron Replacement Deficiency Anemia Patients Initiating Oral Iron Replacement
Effect of Iron Supplements on the Growth of Enteric Pathogens
Retrospective Evaluation of the Effect of Iron (Fe) Infusion on Complications in Anemic Patients Undergoing Thoracotomy
Effect of Iron Source on the Growth of Enteric Pathogens
Compare Efficacy/Safety of Repeat Doses of Ferumoxytol With Iron Sucrose in CKD Subjects With IDA and on Hemodialysis
IV Iron Versus Standard Treatment for Iron Deficiency Anemia in the Emergency Department
Nutrition Intervention to Address Anemia Among Adolescent Girls in Liberia